Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Merck Loses Protection for Patent on Zocor
Unusual Presentation of Guillain-Barré Syndrome After Mandibular Fracture Treatment: A Review of the Literature and a New Case.
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
[Good practice in prophylactic care: prophylactic care and professional activation of employees with multiple sclerosis].
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
Can multiple sclerosis as a cognitive disorder influence patients' dreams?
Neurobehavioral and cytotoxic effects of vanadium during oligodendrocyte maturation: A protective role for erythropoietin.
Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development.
Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications.
Distinct and Atypical Intrinsic and Extrinsic Cell Death Pathways between Photoreceptor Cell Types upon Specific Ablation of Ranbp2 in Cone Photoreceptors.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review.
Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1.
Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study.
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier.
Efficacy of the ANAM General Neuropsychological Screening battery (ANAM GNS) for Detecting Neurocognitive Impairment in a Mixed Clinical Sample.
Myelin morphology and axon pathology in demyelination during experimental autoimmune encephalomyelitis.
Cytokine-Regulated Neutrophil Recruitment Is Required for Brain but Not Spinal Cord Inflammation during Experimental Autoimmune Encephalomyelitis.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Reducing clinical trial risk in multiple sclerosis.
Pages
« first
‹ previous
…
419
420
421
422
423
424
425
426
427
…
next ›
last »